Kevin Latinis

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Brad H. Rovin, Richard Furie, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 1.4K citations

Medicine, Immunology, Pharmacotherapy +16

Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace et al. · Arthritis & Rheumatism · 2009 · 1.4K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus

William Stohl, Falk Hiepe, Kevin Latinis et al. · Arthritis & Rheumatism · 2012 · 416 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

P. Emery, Atul Deodhar, William F. C. Rigby et al. · Annals of the Rheumatic Diseases · 2010 · 347 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The c-Jun N-Terminal Kinase Cascade Plays a Role in Stress-Induced Apoptosis in Jurkat Cells by Up-Regulating Fas Ligand Expression

Mary Faris, Niels Kokot, Kevin Latinis et al. · The Journal of Immunology · 1998 · 235 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17